Qianjin Pharmaceuticals (600479.SH): The restructuring proposal will be reviewed on August 18th.

Wisdom Financial News APP, Qianjin Pharmacy (600479.SH) announced that the company plans to purchase 28.92% of the equity of Hunan Qianjin Xiangjiang Pharmacy Co., Ltd. and 68.00% of the equity of Hunan Qianjin Xielihua Pharmacy Co., Ltd. through the issuance of shares and cash payment. According to the announcement of the Shanghai Stock Exchange Merger and Acquisition Review Committee's "Shanghai Stock Exchange Merger and Acquisition Review Committee's 12th Review Meeting Announcement in 2025", the Shanghai Stock Exchange Merger and Acquisition Review Committee will hold the 12th meeting for the review of mergers and acquisitions on August 18, 2025, to review the application for the company's transaction.